Cargando…

Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence

GOALS: To determine whether an 18 single nucleotide polymorphisms (SNPs) polygenic risk score (PRS18) improves breast cancer (BC) risk prediction for women at above-average risk of BC, aged 40–49, in a Central European population with BC incidence below EU average. METHODS: 502 women aged 40–49 year...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oblak, Tjaša, Škerl, Petra, Narang, Benjamin J., Blagus, Rok, Krajc, Mateja, Novaković, Srdjan, Žgajnar, Janez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587756/ https://www.ncbi.nlm.nih.gov/pubmed/37857130 http://dx.doi.org/10.1016/j.breast.2023.103590

Ejemplares similares

Breast Cancer Risk Based on Adapted IBIS Prediction Model in Slovenian Women Aged 40–49 Years - Could it be Better?
por: Oblak, Tjasa, et al.
Publicado: (2020)

Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model
por: Gallagher, Shannon, et al.
Publicado: (2021)

A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model
por: Brentnall, Adam R, et al.
Publicado: (2019)

Comparative Analysis between the Gail, Tyrer-Cuzick and BRCAPRO Models for Breast Cancer Screening in Brazilian Population
por: Stevanato, Kely Paviani, et al.
Publicado: (2019)

Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry
por: Pal Choudhury, Parichoy, et al.
Publicado: (2021)

Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort
por: Brentnall, Adam R., et al.
Publicado: (2015)

Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire
por: Vianna, Fernanda Sales Luiz, et al.
Publicado: (2019)

Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I
por: Warwick, Jane, et al.
Publicado: (2014)

Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China
por: Zhang, Le, et al.
Publicado: (2018)

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families
por: NOVAKOVIĆ, SRDJAN, et al.
Publicado: (2012)

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families
por: Krajc, Mateja, et al.
Publicado: (2008)

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
por: Stegel, Vida, et al.
Publicado: (2011)

Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing
por: Stegel, Vida, et al.
Publicado: (2022)

Screening Strategy Modification Based on Personalized Breast Cancer Risk Stratification and its Implementation in the National Guidelines – Pilot Study
por: Krajc, Mateja, et al.
Publicado: (2020)

Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk
por: Strojnik, Ksenija, et al.
Publicado: (2021)

BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome
por: Blatnik, Ana, et al.
Publicado: (2022)

Identification of Spliceogenic Variants beyond Canonical GT-AG Splice Sites in Hereditary Cancer Genes
por: Dragoš, Vita Šetrajčič, et al.
Publicado: (2022)

The Prevalence of Occult Ovarian Cancer in the Series of 155 Consequently Operated High Risk Asymptomatic Patients – Slovenian Population Based Study
por: Gornjec, Andreja, et al.
Publicado: (2020)

Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma
por: Peric, Barbara, et al.
Publicado: (2011)

Quality assured implementation of the Slovenian breast cancer screening programme
por: Jarm, Katja, et al.
Publicado: (2021)

Genetic Counselling, BRCA1/2 Status and Clinico-pathologic Characteristics of Patients with Ovarian Cancer before 50 Years of Age
por: Cvelbar, Mirjam, et al.
Publicado: (2017)

Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families
por: Peric, Barbara, et al.
Publicado: (2008)

New Approach for Detection of Normal Alternative Splicing Events and Aberrant Spliceogenic Transcripts with Long-Range PCR and Deep RNA Sequencing
por: Dragoš, Vita Šetrajčič, et al.
Publicado: (2021)

Comment on: “Occupational exposures and male breast cancer: A nested case-control study in the nordic countries”
por: Oblak, Tjasa
Publicado: (2019)

Two Novel NF1 Pathogenic Variants Causing the Creation of a New Splice Site in Patients With Neurofibromatosis Type I
por: Setrajcic Dragos, Vita, et al.
Publicado: (2019)

SNPs for breast cancer risk assessment
por: Cuzick, Jack, et al.
Publicado: (2017)

Clear Cell Carcinoma Arising in Low-Grade Mullerian Adenosarcoma: First Reported Case with Insight into Molecular Profile
por: Gašljević, Gorana, et al.
Publicado: (2023)

Polygenic risk scores and breast cancer risk prediction
por: Roberts, Eleanor, et al.
Publicado: (2023)

Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma
por: Gornjec, Andreja, et al.
Publicado: (2019)

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
por: Mavaddat, Nasim, et al.
Publicado: (2019)

Expression of Longevity Genes Induced by a Low-Dose Fluvastatin and Valsartan Combination with the Potential to Prevent/Treat “Aging-Related Disorders”
por: Janić, Miodrag, et al.
Publicado: (2019)

SNPs in lncRNA Regions and Breast Cancer Risk
por: Suvanto, Maija, et al.
Publicado: (2020)

Polygenic risk scores for prediction of breast cancer risk in Asian populations
por: Ho, Weang-Kee, et al.
Publicado: (2022)

Breast cancer risk assessment and risk distribution in 3,491 Slovenian women invited for screening at the age of 50; a population-based cross-sectional study
por: Jarm, Katja, et al.
Publicado: (2023)

Does Regular Quality Control Improve the Quality of Surgery in Slovenian Breast Cancer Screening Program?
por: Perhavec, Andraz, et al.
Publicado: (2020)

Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk Models
por: Li, Sherly X, et al.
Publicado: (2021)

The role of polygenic risk scores in breast cancer risk perception and decision-making
por: Riddle, Leslie, et al.
Publicado: (2023)

Similar Population of CD133+ and DDX4+ VSEL-Like Stem Cells Sorted from Human Embryonic Stem Cell, Ovarian, and Ovarian Cancer Ascites Cell Cultures: The Real Embryonic Stem Cells?
por: Virant-Klun, Irma, et al.
Publicado: (2019)

Combined effect of low-penetrant SNPs on breast cancer risk
por: Harlid, S, et al.
Publicado: (2012)

A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue
por: Klančar, Gašper, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1meusr5cfeb70ej1pv4idnl6ho